Sort
326,823 grants matching “clinical trial”
PATHOGENESIS AND TREATMENT OF ACUTE HIV INFECTION
$2,264,709Massachusetts General Hospital · U01 · FY2004 · AI
Protocolized Care for Early Septic Shock (ProCESS)
$2,264,684Derek C Angus · University Of Pittsburgh At Pittsburgh · P50 · FY2006 · GM
Southeast Cancer Control Consortium, Inc
$2,264,660James Norman Atkins · Southeast Clinical Oncol Res Consortium · U10 · FY2010 · CA
Human neural stem cell therapy for the treatment of cervical spinal cord injury (
$2,264,400Aileen J Anderson · University Of California-Irvine · U01 · FY2013 · NS
Creatine Safety, Tolerability, and Efficacy in Huntington's Disease: CREST-E
$2,264,317Steven M Hersch · Massachusetts General Hospital · U01 · FY2008 · AT
Creatine Safety, Tolerability, and Efficacy in Huntington's Disease: CREST-E
$2,264,317Steven M Hersch · Massachusetts General Hospital · U01 · FY2009 · AT
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
$2,264,107Alan David D'andrea · Dana-Farber Cancer Inst · P50 · FY2021 · CA
Integrative Pathophysiology of Solid Tumors
$2,264,020Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2015 · CA
Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN)
$2,263,744Augusto C Ochoa · Lsu Health Sciences Center · UG1 · FY2019 · CA
The Johns Hopkins University - Uganda Clinical Trials Unit
$2,263,627Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2023 · AI
Radiation and checkpoint blockade for cancer immune therapy
$2,263,439Robert H Vonderheide · University Of Pennsylvania · P01 · FY2022 · CA
Translational Hearing Center
$2,263,327Peter S Steyger · Creighton University · P20 · FY2021 · GM
16/16 Action for Health in Diabetes Extension Study Biostatistics Research Center
$2,263,271Mark Andrew Espeland · Wake Forest University Health Sciences · U01 · FY2017 · DK
Maternal and infant immunization to eliminate breast milk transmission of HIV-1
$2,263,268Sallie R. Permar · Duke University · P01 · FY2017 · AI
COBRE GRANT
$2,262,935Marwan Noel Sabbagh · Cleveland Clinic Foundation · P20 · FY2019 · GM
Diagnosis, Pathophysiology And Molecular Biology of Pheochromocytoma and Paraganglioma
$2,262,733Karel Pacak · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2020 · HD
HEAL: Probe/Drug Lead Production
$2,262,666Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Development of a cell replacement therapy to treat retinal degenerative blindness
$2,262,500Budd A Tucker · University Of Iowa · DP2 · FY2010 · OD
Translational Research in Breast Cancer
$2,262,139C Kent Osborne · Baylor College Of Medicine · P50 · FY2012 · CA
Pre-clinical Translational Research Facility
$2,262,089Mark Gilbert · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Phase I Clinical Trial Unit for Therapeutics
$2,261,800Salama Balume · Dynport Vaccine Company, Llc · N01 · FY2014 · AI
Investigating the mechanisms by which systemic inflammation promotes Alzheimerâs disease: Asthma as a model and modifiable risk factor
$2,261,120Melissa A Rosenkranz · University Of Wisconsin-Madison · RF1 · FY2023 · AG
Commercialization Readiness Program (CRP) for Bioabsorbable Magnesium (Mg) Implants for Craniomaxillofacial Surgical Systems
$2,260,835Stephen Lebeau · Nanomag, Llc · R44 · FY2020 · DE
Women's Health Initiative Cancer Survivor Cohort
$2,260,718Garnet L. Anderson · Fred Hutchinson Cancer Research Center · UM1 · FY2017 · CA
Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders
$2,260,692Carlos Zarate · National Institute Of Mental Health · ZIA · FY2016 · MH